Medical Psychedelics
Breaking down barriers to research: A timeline of the CDPRG’s workflow.
Release of the ACMD’s Barriers to research report.
We eagerly await the release of Part II of the ACMD’s report investigating barriers to research in which we expect recommendations concerning the rescheduling of psilocybin and other psychedelics.
(Upcoming)
#PsilocybinAccessRights hard launch at Medicine Festival
The public launch of the #PAR campaign was at Medicine Festival 2022, and involved collecting testimonies from the public, sending PAR postcards to MPs and the public launch of the PAR website.
(August 2022)
15 top psychiatrists ask the Royal College of Psychiatrists to support the request for the Home Office to reschedule psilocybin
In a letter sent by Prof David Nutt of DrugScience as part of the #PsilocybinAccessRights campaign.
(July 2022)
Barriers to researching psilocybin and other controlled drugs: what are our options?
This report was sent to the ACMD and the Home Office in response to the recommendations made by the ACMD in Part 1 of their “Barriers to Research” to reiterate that rescheduling with restrictions is the best course of action for research into psilocybin and other controlled drugs.
(April 2022)
Infographic and letter from CDPRG to all MPs from Crispin Blunt and Charlotte Nicholls.
Our chairman Crispin Blunt collaborated with Labour MP Charlotte Nicholls to deliver cross-party support for the rescheduling of psilocybin, making the case with an infographic featuring polling data showing the majority of the public; and all MPs, even Conservative MPs; support evidence based drug policy reform.
(February 2022)
Psychiatrists’ and ClusterBusters’ letters to Home Office.
Leading psychiatrists wrote a letter to the Home Office in support of an open letter signed by 161 brave cluster headache sufferers, urgently calling for the rescheduling of psilocybin to enable treatment research into this debilitating condition which is currently obstructed by its Schedule 1 status.
(February 2022)
“Demand grows for UK ministers to reclassify psilocybin for medical research.” The GuaRDIAN.
"Prof Allan Young, Prof Karl Friston and Prof Simon Wessely want the ministers to commission Sir Chris Whitty, the chief medical officer for England, ‘to assess the evidence for the harms and utility of psilocybin with a view to rescheduling this promising medicine and experimentally useful compound at the earliest opportunity.’”
(March 2022)
Prime Minister’s Question from Charlotte Nicholls MP.
This question posed to Boris Johnson invoked the plight of veterans with post-combat trauma, which can be uniquely effectively alleviated by psychedelic-assisted therapies, in making the case for rescheduling psilocybin to enable domestic access to these treatments as those in need must currently travel to other jurisdictions to access healing with psilocybin.
(January 2022)
DE MINIMIS REPORT
(November 2022)
Prime Minister’s Question from Crispin Blunt.
Home Office Question on Rescheduling Psilocybin (video above).
(October 2021)
September 2021
“Warning UK faces 'worst research blackout in history' as Home Office falters on drug law.” The Express. September 19, 2021.
Briefing to Health Minister.
August 2021
#PsilocybinAccessRights (#PAR) soft launch at Breaking Convention 2021.
June 2021
Written Parliamentary Question.
YouGov polling results from Psilonautica and DrugScience show the majority of the British public support rescheduling psilocybin for research and treatment.
MAY 2021
PM confirms sign off on rescheduling psilocybin in a meeting with CDPRG chairman Crispin Blunt.
2x Written Parliamentary Questions.
Submission made to ACMD call for evidence on “Barriers to research.”
APril 2021
Submissions and meetings with Health Minister and TIGGR committee.
March 2021
ACMD announce review of ‘Barriers to research beyond cannabinoids.”
January 2021
Meeting and submissions to Number 10 Policy Unit.
September 2020
Joint meeting of APPG for Drug Policy Reform and APPG for Mental Health.
In September 2020, the APPG for Drug Policy Reform heard expert commentary from the front lines of the UK's battle against the mental health crisis, which made clear that Britain has got to unlock the therapeutic potential of psilocybin. The CDPRG is thankful to our collaborators for coming together to recreate these corresponding presentations for public release.
August 2020
Police and Crime Commissioners support rescheduling psilocybin.
JULY 2020
Release of Medicinal Use of Psilocybin report and press coverage.
With Jeff Smith MP, co-chair of the APPG for Drug Policy Reform, Crispin Blunt presents a copy of Medicinal Use of Psilocybin to the Rt. Honourable Kit Malthouse, Minister for Crime and Policing.
January 2020
Public strategy meeting.
August 2019
Inception of the campaign.